Testing of the Anti Cancer Drugs CB-839 HCl (Telaglenastat) and MLN0128 (Sapanisertib) in Advanced Stage Non-small Cell Lung Cancer
Testing of the Anti Cancer Drugs CB-839 HCl (Telaglenastat) and MLN0128 (Sapanisertib) in Advanced Stage Non-small Cell Lung Cancer
Active, not recruiting · NCT04250545 · Registry updated 2026-05-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Testing of the Anti Cancer Drugs CB-839 HCl (Telaglenastat) and MLN0128 (Sapanisertib) in Advanced Stage Non-small Cell Lung Cancer | Leptomeningeal Neoplasms, Neoplasms by Site, Thoracic Neoplasms, brain disorder, bronchial neoplasm, bronchogenic carcinoma, central nervous system cancer, central nervous system disorder, lung disorder, lung neoplasm, metastatic malignant neoplasm in the brain, neoplasm, nervous system disorder, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, tumor of meninges | Active, not recruiting | Phase 1 | 2026-05-26 | NCT04250545 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| City of Hope at Irvine Lennar | Irvine | United States | 104 |
| City of Hope Comprehensive Cancer Center | Duarte | United States | 263 |
| Keck Medicine of USC Koreatown | Los Angeles | United States | 39 |
| Los Angeles General Medical Center | Los Angeles | United States | 179 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| University of California Davis Comprehensive Cancer Center | Sacramento | United States | 299 |
| USC / Norris Comprehensive Cancer Center | Los Angeles | United States | 249 |